Development and optimisation of photonic crystal based nanosensors

Show simple item record

dc.contributor.advisor O'Riordan, Alan en
dc.contributor.author Mitchell, Micki
dc.date.accessioned 2016-07-01T11:39:12Z
dc.date.available 2016-07-01T11:39:12Z
dc.date.issued 2016
dc.date.submitted 2016
dc.identifier.citation Mitchell, M. 2016. Development and optimisation of photonic crystal based nanosensors. PhD Thesis, University College Cork. en
dc.identifier.endpage 179 en
dc.identifier.uri http://hdl.handle.net/10468/2819
dc.description.abstract This thesis involved the development of two Biosensors and their associated assays for the detection of diseases, namely IBR and BVD for veterinary use and C1q protein as a biomarker to pancreatic cancer for medical application, using Surface Plasmon Resonance (SPR) and nanoplasmonics. SPR techniques have been used by a number of groups, both in research [1-3] and commercially [4, 5] , as a diagnostic tool for the detection of various biomolecules, especially antibodies [6-8]. The biosensor market is an ever expanding field, with new technology and new companies rapidly emerging on the market, for both human [8] and veterinary applications [9, 10]. In Chapter 2, we discuss the development of a simultaneous IBR and BVD virus assay for the detection of antibodies in bovine serum on an SPR-2 platform. Pancreatic cancer is the most lethal cancer by organ site, partially due to the lack of a reliable molecular signature for diagnostic testing. C1q protein has been recently proposed as a biomarker within a panel for the detection of pancreatic cancer. The third chapter discusses the fabrication, assays and characterisation of nanoplasmonic arrays. We will talk about developing C1q scFv antibody assays, clone screening of the antibodies and subsequently moving the assays onto the nanoplasmonic array platform for static assays, as well as a custom hybrid benchtop system as a diagnostic method for the detection of pancreatic cancer. Finally, in chapter 4, we move on to Guided Mode Resonance (GMR) sensors, as a low-cost option for potential use in Point-of Care diagnostics. C1q and BVD assays used in the prior formats are transferred to this platform, to ascertain its usability as a cost effective, reliable sensor for diagnostic testing. We discuss the fabrication, characterisation and assay development, as well as their use in the benchtop hybrid system. en
dc.description.sponsorship European Union (Framework 7) en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher University College Cork en
dc.rights © 2016, Micki Mitchell. en
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/ en
dc.subject Bioplasmonics en
dc.subject Diagnostics en
dc.subject Label-free en
dc.subject Nanoarrays en
dc.subject Pancreatic cancer en
dc.subject Biosensor en
dc.title Development and optimisation of photonic crystal based nanosensors en
dc.type Doctoral thesis en
dc.type.qualificationlevel Doctoral en
dc.type.qualificationname PhD (Science) en
dc.internal.availability Full text available en
dc.check.info No embargo required en
dc.description.version Accepted Version
dc.contributor.funder European Union en
dc.description.status Not peer reviewed en
dc.internal.school Chemistry en
dc.internal.school Tyndall National Institute en
dc.check.type No Embargo Required
dc.check.reason No embargo required en
dc.check.opt-out Not applicable en
dc.thesis.opt-out false
dc.check.embargoformat Not applicable en
ucc.workflow.supervisor alan.oriordan@tyndall.ie
dc.internal.conferring Summer 2016 en


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2016, Micki Mitchell. Except where otherwise noted, this item's license is described as © 2016, Micki Mitchell.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement